宜宾怎么样可以隆鼻宜宾内双怎样变双眼皮,宜宾冰点脱毛多钱,专业做双眼皮保持时间宜宾,宜宾玻尿酸隆鼻过程,宜宾双眼皮有几种手术,宜宾埋线双眼皮的线,宜宾祛斑一般多少钱

BEIJING, May 14 (Xinhua) -- The uranium subsidiary of China Guangdong Nuclear Power Group (CGNPG) has said it is developing two large mines in the mainland.The two mines will be located in south China's Guangdong province and northwest China's Xinjiang Uygur Autonomous Region, according to Saturday's China Daily.The move is likely to add as much as 1,000 tonnes to the country's annual production capacity of the nuclear fuel."The two mines are expected to start operation in 2013, each with an annual production capacity of no more than 500 tonnes," the newspaper quoted Zhou Zhenxing, chairman of CGNPG Uranium Resources Co (CGNPG-URC) as saying.

CAIRO, Jan. 23 (Xinhua) -- The first training session for Egyptian Chinese language teachers to improve their teaching ability started on Sunday in Cairo.The session, under the supervision of the Chinese Confucius institute, will concentrate on the exchange of experiences in teaching the Chinese language in Egypt and the enhancement of Egyptian teachers' ability to make better use of the textbooks.The three-day training session will contain language and cultural courses by professors and instructors from famous Chinese universities such as Beijing University and Beijing Foreign Studies University, said Li Shengjun, head of the Confucius Institute at Cairo University.Nearly 60 Egyptian Chinese language teachers, including 14 professors, from universities including Cairo University, Ain Shams University and Minya University will attend the training courses.China has established 691 Confucius institutes and classes in around 69 countries until 2010, including nine in the Arab countries.

MOSCOW, March 11 (Xinhua) -- A new crew which are to depart for the International Space Station (ISS) at the end of March have successfully passed the pre-flight tests, the Russian Federal Space Agency (Roscosmos) announced on Friday.At a press conference held at Russia's Cosmonauts Training Center, a Roscosmos spokesman said two Russian cosmonauts Andrei Borisenko and Alexander Samokutyaev and a U.S. astronaut Ronald Garn will leave for the ISS by a Russian Soyuz-TM-21 spacecraft on March 30.On March 17, the three crew members and their backup crew members, Anton Shkaplerov, Anatoly Ivanishin and Daniel Burbank, will make their final preparation for the space trip in the Baikonur space site in Kazakhstan.According to the Roscosmos, the three main crew members are expected to spend 170 days in the ISS. During the period, they will receive two U.S. space shuttles and three Russian Progress cargo ships and conduct a spacewalk.The agency also revealed the Soyuz-TM-21 spacecraft scheduled for the ISS was named as Gagarin.The year of 2011 was announced as Russia's Space Year to celebrate the 50th anniversary of the launch of the first Russian manned space flight carrying cosmonaut Yuri Gagarin in 1961 for a 90-minute flight.

UNITED NATIONS, Feb. 11 (Xinhua) -- China Friday urged the United Nations and Security Council to give more attention to Africa and called on the international community to provide greater support to the region in order to maintain peace and security. Addressing an open debate of the UN Security Council on the interdependence between security and development, Li Baodong, China's permanent representative to the UN said the inter-linkages between peace and development are most pronounced in Africa. There will be no world prosperity and stability without peace and development in the region. He called on the international community to provide greater support and more assistance to regional countries, AU and other regional and subregional organizations to maintain African peace and security. Li stressed that security and development are mutually linked and reinforcing. To safeguard peace and promote development, the international community should increase development input and eradicate root causes of conflicts. "Poverty and underdevelopment are the major causes for triggering conflicts and breeding terrorism. The developed countries should further increase its development aid, provide debts relief to developing countries, open up markets, transfer technology and help the developing countries to achieve the Millennium Development Goals as soon as possible." Li said development can be anchored only in an environment free from war and turbulence. The UN and Security Council should vigorously promote peaceful culture, encourage and support peaceful resolutions to disputes through dialogue, consultations and good offices. In addition, greater emphasis should be given to peacebuilding so as to prevent relapse into conflicts. "In post-conflict countries and regions, simultaneous progress should be made in the fields of politics, security and development throughout development and reconstruction process, " said Li. "Capacity building should be prioritized in the post-conflict countries to enhance governance, provide basic services, advance development and reconstruction so that the people could enjoy peaceful 'dividend' quickly. This is conducive to consolidating political reconciliation process and stabilizing post-conflict situations, " he said.

WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.